17th JPIAMR transnational call for research projects - AMR Interventions 2024 (IMPACT)

General Information

• Type: Partner looking for project
• Organisation: Cellexus
• Country: United Kingdom (UK)
• Career stage: Other.

Research area

• Scientific area(s) of the call:
  1. Topic 2: Improve and/or, compare and/or evaluate strategies, technologies, treatments, methods, protocols or data collection based on existing interventions, aiming to prevent or reduce the emergence or spread of antibacterial or antifungal resistance or to treat/cure infections caused by resistant bacteria/fungi and recommend new policies.
• Subtopics:
  1. Improve and/or compare and/ or evaluate the effectiveness of existing interventions (e.g. cost effectiveness clinical utility, socio-economic adaptability, reducing AMR emergence, spread, transmission, treatment etc.)

• One Health Setting:

  Human Health

  Animal Health (incl. wildlife, livestock, acquatic organisms, and companion animals)
  Plants (incl. trees and crops)
  Environment (incl. natural and built)

• Keywords:

  bacteriophage; fungi; cell-culture; bioreactor; bioprocess

• Brief description of your expertise / expertise you are looking for:

  Cellexus International is a Scottish company, manufacturing the only single use, purely airlift bioreactors available on the market. The CellMaker allows for efficient, yet gentle mixing and easy scaling from 1.5L to 50L in a GMP compliant system. Single use, airlift bioreactors can reduce both the economical and environmental impact of biologics manufacturing. The single use system reduces downtime and reduces energy, water and chemical usage required to clean and certify reusable vessels. CellMaker bioreactor systems can be customised to have the most suitable, cost effective system for your process.

• Brief description of your project / the project you would like to join:

  We are passionate about supporting the fight against AMR. The CellMaker systems have been developed and optimised for phage, microbial applications, microbiome, plant cells, fungi, insect and mammalian cells. Efficient aeration and the lack of impeller, meaning no shear stress on the cells, allows for clinical biologics production from viral vectors to phage therapies. Please reach out if you are interested in using our technology or collaborating on a project.

Anna Cornfield

• Organisation: Cellexus
• Position: Business Development Manager
• E-mail: anna@cellexus.com
• Phone: 01382666357
• Web: cellexus.com/